A wealth of anti-tumor lymphocyte subsets was observed infiltrating the ICD-high subtype, including activated B cells, activated CD4+ T cells, activated CD8+ T cells, central memory CD4+ T cells, and effector CD8+ T cells (Figure 3C-3D). This evidence concerns the gene CD4 and neoplasm.